50 studies found for:    Open Studies | "Growth Disorders"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Growth Disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
Condition: Growth Disorders
Intervention: Device: easypod™
2 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia
Condition: Growth Disorders
Intervention: Device: easypod™
3 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden
Condition: Growth Disorders
Intervention: Device: easypod™
4 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece
Condition: Growth Disorders
Intervention: Device: Easypod™
5 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia
Condition: Growth Disorders
Intervention: Device: easypod™
6 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea
Condition: Growth Disorders
Intervention:
7 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
Condition: Growth Disorders
Intervention: Device: easypod™
8 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East
Condition: Growth Disorders
Intervention: Device: easypod™
9 Recruiting Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
Condition: Growth Disorders
Intervention: Device: easypod™
10 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
Condition: Growth Disorders
Intervention: Device: easypod™
11 Recruiting To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Taiwan (ECOS TWN)
Condition: Growth Disorders
Intervention: Device: easypod™
12 Recruiting Study of Proteus Syndrome and Related Congenital Disorders
Conditions: Growth Disorder;   Mental Retardation;   Multiple Abnormalies
Intervention:
13 Not yet recruiting Individualized Fortification of Breast Milk
Conditions: Postnatal Growth Disorder;   Neurodevelopment
Interventions: Dietary Supplement: Individualized fortification of breast milk;   Dietary Supplement: Routine fortification of breast milk
14 Recruiting A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders
Condition: Growth Hormone Disorders
Intervention:
15 Recruiting European Increlex® (Mecasermin [rDNA Origin] Injection) Growth Forum Database - IGFD Registry
Condition: IGF1 Deficiency
Intervention: Drug: Increlex®
16 Not yet recruiting Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women
Condition: Intrauterine Growth Restriction
Interventions: Other: Bold sequence patients test;   Other: Bold sequence
17 Unknown  Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
Condition: Intrauterine Growth Retardation
Intervention:
18 Recruiting The Reus-Tarragona Birth Cohort Study of Early Development and Ageing.
Condition: Intrauterine Development
Intervention: Other: Observational
19 Recruiting Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
Conditions: Dyskeratosis Congenita;   Hoyeraal Hreidarsson Syndrome;   Revesz Syndrome;   Aplastic Anemia
Interventions: Biological: alemtuzumab;   Drug: Fludarabine;   Drug: Cyclosporins;   Drug: Mycophenolate mofetil
20 Recruiting Obesity and Oral Contraceptive Failure
Conditions: Contraception;   Fetal Growth Retardation;   Infant, Small for Gestational Age;   Obesity
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years